J. Theodore Phillips, MD, PhD (Moderator)
Clinical Associate Professor of Neurology
University of Texas Southwestern Medical Center
J. Theodore Phillips, MD, is the director of the Multiple Sclerosis Center at Texas Neurology in Dallas. He serves as a clinical associate professor of neurology at the University of Texas Southwestern Medical Center and as an attending neurologist at Baylor University Medical Center in Dallas.
Dr. Phillips is a graduate of the University of Texas at Austin with special honors in chemistry, and received his MD and his PhD in immunology, and neurology residency training from the University of Texas Southwestern Medical Center at Dallas.
He is a principal developer of a national registry for MS (MSTRAC) and is a principal investigator in several ongoing clinical treatment trials in MS.
Frederick E. Munschauer, MD
Professor of Clinical Neurology and Internal Medicine
University at Buffalo School of Medicine and Biomedical Sciences
Frederick E. Munschauer, MD, is a board-certified specialist in neurology and internal medicine with a subspecialty in critical care. He is a professor of clinical neurology and internal medicine at the State University of New York at Buffalo School of Medicine and Biomedical Sciences and serves as interim chairman of the department of neurology, as well as acting chief of The Jacobs Neurological Institute of Kaleida Health, Buffalo, New York.
Dr. Munschauer received his medical degree from McGill University, Montreal, Quebec, Canada, and completed an internship and residency in internal medicine and a residency in neurology at The Johns Hopkins Hospital, Maryland, USA. He also completed a fellowship in neurological and neurosurgical intensive care at The National Hospital for Nervous Disease, London, UK. Dr. Munschauer is a member of the American Academy of Neurology, the American Heart Association, the American Medical Association, the American Society of Neuroimaging, and the Society of Critical Care Medicine.
Dr. Munschauer has researched extensively in the use of interferon-b1a (IFN-b1a) as treatment for relapsing-remitting multiple sclerosis (MS) and was coinvestigator of phase III clinical trials and the CHAMPS study. His publications include the phase III clinical trial results, as well as the rationale for early treatment of MS with IFN-b1a, and managing side effects of IFN-b1a in patients. Dr. Munschauer lectures nationally and internationally on the use of IFN-b1a in patients with MS and is considered one of the leaders in the field of MS treatment.
Shirley O'Leary, RN, MSCN
Multiple Sclerosis Center
Texas Neurology
Shirley O'Leary, RN, MSCN, practices with J. Theodore Phillips, MD, at the Multiple Sclerosis Center at Texas Neurology. Over the last 10 years she has been involved in all aspects of patient care, including MS research. She is a member of the International Organization of MS Nurses and the American Association of Neuroscience Nurses and has collaborated on several published MS articles.
|
